We are live on ! Find out more
WT

Wellcome Trust Portfolio holdings

AUM $9.01B
1-Year Est. Return 12.05%
This Fund
S&P 500
This Quarter Est. Return
+3.08%
1 Year Est. Return
+12.05%
3 Year Est. Return
+59.66%
5 Year Est. Return
+58.12%
10 Year Est. Return
+403.84%
AUM
$4.15B
AUM Growth
+$89.2M
Cap. Flow
+$19.2M
Cap. Flow %
0.46%
Top 10 Hldgs %
55.78%
Holding
40
New
4
Increased
4
Reduced
4
Closed
9

Top Buys

Rank Stock Value
1
RDUS
Radius Health, Inc.
RDUS
+$15.9M
2
BAC icon
Bank of America
BAC
+$7.77M
3
TWTR
Twitter, Inc.
TWTR
+$1.6M
4
CSCO icon
Cisco
CSCO
+$1.19M
5
AAPL icon
Apple
AAPL
+$426K

Sector Composition

Rank Sector Weight
1 Financials 25.13%
2 Technology 23.86%
3 Communication Services 19.25%
4 Consumer Staples 11.38%
5 Energy 7.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TWTR
26
CALL
DELISTED
Twitter, Inc.
TWTR
$20.5M 0.49%
+500,000
New +$18.9M
JPM icon
27
CALL
JPMorgan Chase
JPM
$919B
$17.3M 0.42%
300,000
-200,000
-40% -$11.2M
MS icon
28
CALL
Morgan Stanley
MS
$320B
$16.2M 0.39%
500,000
BIDU icon
29
Baidu
BIDU
$35.8B
$14.6M 0.35%
78,000
VXRT
30
DELISTED
Vaxart
VXRT
$137K ﹤0.01%
+4,389
New +$183K
OXFD
31
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$73K ﹤0.01%
+4,350
New +$78.3K
AMZN icon
32
Amazon
AMZN
$2.44T
-44,000
Closed -$740K
BKNG icon
33
Booking.com
BKNG
$156B
-2,500
Closed -$119K
BMRN icon
34
BioMarin Pharmaceuticals
BMRN
$11.9B
-4,978
Closed -$340K
CMG icon
35
Chipotle Mexican Grill
CMG
$43.9B
-80,000
Closed -$909K
CRM icon
36
Salesforce
CRM
$154B
-6,912
Closed -$394K
V icon
37
Visa
V
$703B
-32,472
Closed -$1.75M
CERN
38
DELISTED
Cerner Corp
CERN
-6,634
Closed -$373K
FPRX
39
DELISTED
Five Prime Therapeutics, Inc.
FPRX
-364,670
Closed -$7.17M
ATHN
40
DELISTED
Athenahealth, Inc.
ATHN
-1,348
Closed -$216K

Similar funds

Wellcome Trust's Q2 2014 Portfolio in Review

As of Q2 2014, Wellcome Trust held 40 positions worth $4.15B, up 2.2% from $4.06B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Wellcome Trust's Q2 2014 filing shows 4 new, 4 increased, 4 reduced and 9 closed positions. Its largest new stake was Radius Health, Inc.: 1,726,841 shares worth $22.4M. The largest sale was Five Prime Therapeutics, Inc., an estimated $7.17M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 26% a quarter earlier, followed by Technology and Communication Services.

  • Wellcome Trust's largest Q2 2014 buy was Radius Health, Inc.: 1,726,841 shares worth $22.4M.
  • Wellcome Trust added most to Bank of America in Q2 2014, an estimated $7.77M increase.
  • Wellcome Trust's biggest Q2 2014 reduction was Verizon, cutting an estimated $1.45M.
  • Wellcome Trust fully exited Five Prime Therapeutics, Inc. in Q2 2014, selling an estimated $7.17M.
  • Wellcome Trust's ten largest holdings make up 56% of its $4.15B portfolio in Q2 2014.
  • Wellcome Trust opened 4 new positions and closed 9 in Q2 2014.
  • Wellcome Trust's portfolio value rose 2.2% quarter-over-quarter to $4.15B.

Based on Wellcome Trust's 13F filing for Q2 2014, filed 23 Jul 2014.